Endoscopy Devices: Applications and Global Markets

  • July 2013
  • -
  • BCC Research
  • -
  • 118 pages

This report provides:

- An overview of the global market for endoscopy services and equipment by product, company, and geography.
- Analyses of global market trends, with data from 2009 to 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Reviews of endoscope products by their various applications and trends in innovation and sales.
- Examination of the competitive environment, with a special focus on how developing products and technologies are influencing the current standard of patient care.
- Information for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants and anyone interested in the Endoscopy market.

STUDY GOALS AND OBJECTIVES

This report provides a comprehensive analysis of the global market for endoscopy services and equipment. The report will review global markets for endoscope products by their various applications and will forecast trends in innovation and sales in these markets through the year 2018. A range of information will be discussed, including detailed analyses of emerging markets in India and Asia, new products pipelines and new applications for endoscopic technology, and overall industry trends. This information will allow the reader to evaluate and quantify the current market size for specific endoscopic technologies within the overall growing biomedical/pharmaceutical technology market. Forecasts and trends have been developed from a variety of data, including industry sources, company publications, industry benchmarks, and other data sources. Major endoscopy applications, technologies, geographies, and factors influencing the demand for endoscopy services and products will be discussed.

REASONS FOR DOING THE STUDY

The overall medical device market is very large; endoscopy is a significant component of that market. For companies with an effective strategy, market opportunity awaits. However, the ability to develop an effective strategy begins where opportunity exists and ends with effective execution and capturing profit from the opportunity.The endoscopy market is positioned for significant growth in the next five years. This is due, in part, to new applications for the technology, as well as new innovations in the technology itself. The other major factor that will contribute to this growth is the recognition of this technology in emerging markets like Japan and Vietnam. Continued worldwide growth is expected in other geographic areas due to a growing middle class in countries such as India, China, Brazil and Russia.This report addresses critically important topics for analyzing a changing market dynamic, emerging players and technologies, strategies for accessing these emerging markets, and specific disease segments and geographies in order to allow allocation of resources and make effective decisions.

SCOPE OF REPORT

Current and projected endoscopy revenue forecasts during the forecast period (2013 to 2018) are discussed. Endoscopy devices require U.S. Food and Drug Administration FDA premarket manufacturing notification (PMN) approval, European Union Medical Device Directive European Conformity (CE Mark) approval, or similar approvals in other countries. Regulation on endoscopic devices is rigid in terms of proving proof of product safety and efficacy before sale to the medical community. Due to the timing of the release of this report, the figures for 2013 are estimated, except where actual results have been reported.The report includes analysis of the leading competitors, as well as emerging companies in the current worldwide endoscopy market. Profiles of the manufacturers of the leading products are analyzed, their specific product strategies are outlined, and their pipeline of products is discussed. This report looks at companies poised to introduce new products during the forecast period and discusses how these products may change the face of the competitive environment. This competitive environment is examined with special focus on how developing products and technologies are influencing the current standard of patient care. Detailed profiles of the current market leaders and emerging companies are discussed in detail.Market figures are based on revenues at the manufacturers’ level and are projected in 2012-dollar value. Inflation is not calculated in the projection figures.

Trends are assessed based on a number of parameters, including projected sales for existing products, new product introductions, expanded indications for existing products, and finally, for projected changes in the prevalence, diagnosis, and scripting rates for certain diseases.Included in this report are forecasts by product, disease category, and by company for the period from 2013 through 2018. The report is arranged to provide an overview of the endoscopy market by product, company and geography. Forecasts are broken down by geographic region or by country. The worldwide market is analyzed and data provided for each disease sub-segment.Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.All market share data presented is on a global basis unless specifically noted.

INTENDED AUDIENCE

This report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants and anyone interested in the Endoscopy market, its products, its industry participants, and its future.The importance of identifying overall market trends, product opportunities, emerging geographies, merger and acquisition (M&A) opportunities, and insights that provide guidance for sales growth or defensive moves cannot be overstated for a variety of constituents, including:
Established companies in the industry shall benefit from the contents, including corporate strategy, sales and marketing, business development, and research and development.
Emerging companies in this medical device segment must understand specific opportunities for out-licensing, originating from the elements of differentiation of their product or technology as compared to leading, competitive, and emerging therapies. As well, market forecasts can support investment, provided a thorough and detailed substantiation is provided for the market forecast, as is found in this study.
Investment firms evaluating candidates for venture capital or hedged investments will gain insights as to the opportunity and risks that are being encountered in the industry in a product and company specific analysis.
Equity analysts are provided with detailed forecasts for the next five years, substantiated by quantitative analysis that can support further analysis to product and company forecasts over the short and long run.

METHODOLOGY AND INFORMATION SOURCES

In-depth interviews were conducted with leading experts in the field who are executives in companies, industry analysts, and leading medical practitioners in the field.The overall endoscopy sector is comprised of a variety of fast-growing and independent segments. For completeness, the current and forecasted markets are comprised of the total market opportunity for each respective segment. Within each subsection, there is a detailed forecast for each driving mechanism or relevant area of growth.Information to prepare this report was obtained from participating and emerging companies in the endoscopy area, the American Urological Association; the National Heart, Lung, and Blood Institute; Arthroscopy Association of North America; American Society of Gastroenterology; and American Academy of Otolaryngology. Information also came from articles published in medical journals such as the The Journal of Endoscopy, Diagnostic and Therapeutic Endoscopy, Digestive Endoscopy, Circulation, Lancet, and others. Other information originated from the World Health Organization and other government agencies, literature searches, annual reports, 10Ks, and others. Population estimates are based on those reported by the international database of the U.S. Census Bureau.Current and historical revenue figures for individual products have been sourced from company disclosures that exist in the public domain or from government sources.

Table Of Contents

CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 2
SCOPE OF REPORT 2
INTENDED AUDIENCE 3
METHODOLOGY AND INFORMATION SOURCES 4
ANALYST'S CREDENTIALS 4
RELATED REPORTS 4
BCC ONLINE SERVICES 5
DISCLAIMER 5
CHAPTER 2 SUMMARY 7
SUMMARY TABLE TOTAL ENDOSCOPY MARKET, BY SEGMENT, THROUGH 2018 ($
MILLIONS) 7
SUMMARY FIGURE TOTAL ENDOSCOPY MARKET, BY SEGMENT, 2009-2018 ($
MILLIONS) 7
CHAPTER 3 OVERVIEW 10
TABLE 1 GLOBAL ENDOSCOPY REVENUES OF LEADING COMPANIES, THROUGH
2012 ($ MILLIONS) 11
ENDOSCOPY TRENDS AND FORECAST 11
THE ENDOSCOPE AND ENDOSCOPIC PROCEDURES 12
THE ENDOSCOPE 12
THE ENDOSCOPIC PROCEDURE 13
MAJOR COMPANIES IN THE ENDOSCOPY MARKET 14
TABLE 2 LEADING PLAYERS IN VARIOUS ENDOSCOPY SEGMENTS 15
DRIVERS AND RESISTORS FOR THE ENDOSCOPY MARKET 16
DRIVERS 16
RESISTORS 17
REGULATORY DEVELOPMENTS 17
PHYSICIAN PAYMENTS SUNSHINE ACT 18
INCREASING INFLUENCE OF GROUP PURCHASING ORGANIZATIONS (GPOS) 19
COMPARATIVE EFFECTIVENESS RESEARCH (CER) 20
MEDICAL DEVICE EXCISE TAX 20
CHAPTER 4 MEDICAL APPLICATIONS OF ENDOSCOPY 22
UROLOGY ENDOSCOPY 22
TABLE 3 KIDNEY DISEASES COMMONLY MANAGED BY ENDOSCOPY 22
TABLE 4 URETER DISEASES COMMONLY MANAGED BY ENDOSCOPY 22
TABLE 5 BLADDER DISEASES COMMONLY MANAGED BY ENDOSCOPY 23
TABLE 6 PROSTATE DISEASES COMMONLY MANAGED BY ENDOSCOPY 23
TABLE 7 URETHRA DISEASES COMMONLY MANAGED BY ENDOSCOPY 23
NEPHROSCOPY 23
CYSTOSCOPY 24
RESECTOSCOPY 24
UROLOGY ENDOSCOPY INSTRUMENT TYPE AND ACCESSORIES 25
INSTRUMENTS AND TYPES 25
MARKET SIZE FOR UROLOGICAL DEVICES 25
TABLE 8 MARKET SIZE FOR UROLOGICAL ENDOSCOPE DEVICES, THROUGH 2018 ($
MILLIONS) 25
MAJOR PLAYERS IN UROLOGY ENDOSCOPY MARKET 25
LAPAROSCOPY 26
STOMACH RESTRICTIVE PROCEDURES 26
Lap Band 26
Vertical-banded Gastroplasty 27
CHOLECYSTECTOMY 27
APPENDECTOMY 27
HERNIA REPAIR 27
TABLE 9 PENETRATION OF LAPAROSCOPY IN COMMON SURGICAL PROCEDURES IN
THE U.S., 2012 (NUMBER/%) 28
HAND-ASSISTED LAPAROSCOPY 28
TABLE 10 COMMERCIALLY AVAILABLE MUCOSAL ABLATION THERAPY DEVICES 30
LAPAROSCOPY INSTRUMENT TYPE AND ACCESSORIES 30
MARKET SIZE FOR LAPAROSCOPY DEVICES 31
TABLE 11 MARKET SIZE FOR LAPAROSCOPY DEVICES, THROUGH 2018 ($ MILLIONS) 31
MAJOR PLAYERS IN LAPAROSCOPY MARKET 31
GI ENDOSCOPY 31
UPPER GI ENDOSCOPY 31
DOUBLE-BALLOON ENDOSCOPY 32
VIDEO CAPSULE ENDOSCOPY 33
LOWER GI ENDOSCOPY 33
ENDOSCOPIC MUCOSAL RESECTION (EMR) 34
TABLE 12 KEY DEVICE TYPE FOR EMR PROCEDURE 35
ENDOSCOPIC ULTRASOUND SURGERY (EUS) 35
TABLE 13 KEY DEVICE CATEGORIES FOR ENDOSCOPIC ULTRASOUND 36
ENDOSCOPIC SNAKE DEVICES 37
HIGH-DEFINITION SCOPES AND NARROW BAND IMAGING 38
CHROMOENDOSCOPY 38
TABLE 14 CLASSIFICATION OF STAINS USED IN CHROMOENDOSCOPY 39
TABLE 15 COMMERCIALLY AVAILABLE SPRAY CATHETERS 40
GI ENDOSCOPY INSTRUMENT TYPE AND ACCESSORIES 40
MARKET SIZE FOR OF GI ENDOSCOPY DEVICES 41
TABLE 16 MARKET SIZE FOR OF GI ENDOSCOPY DEVICES, THROUGH 2018 ($
MILLIONS) 41
MAJOR PLAYERS IN GI ENDOSCOPY MARKET 41
ARTHROSCOPY 41
KNEE ARTHROSCOPY 42
Types of Knee Injury 43
Annual Volume of Knee Surgeries in the U.S. 43
Arthroscopic Surgery for Acute Knee Injuries 44
TABLE 17 KNEE LIGAMENT DAMAGE AND SURGICAL REQUIREMENTS 44
Pain Management with Lavage and Debridement 45
ARTHROSCOPIC SHOULDER SURGERY 45
TABLE 18 PROCEDURES ROUTINELY EMPLOYED IN ARTHROSCOPIC ROTATOR CUFF
SURGERY 46
ADDITIONAL JOINTS WHERE ARTHROSCOPIC SURGERY IS EMPLOYED 46
WRIST ARTHROSCOPY 47
TABLE 19 COMMON CONDITIONS REQUIRING ARTHROSCOPIC WRIST SURGERY 47
ANKLE ARTHROSCOPY 48
ARTHROSCOPIC SURGERY OF THE ELBOW 49
TABLE 20 SOME COMMON ELBOW DIAGNOSES REVEALED BY ARTHROSCOPIC
INVESTIGATION 49
ARTHROSCOPIC INVESTIGATION OF THE HIP 50
FEMORO-ACETABULAR IMPINGEMENT AND HIP MOBILITY 50
ARTHROSCOPY INSTRUMENT TYPE AND ACCESSORIES 51
MARKET SIZE FOR OF ARTHROSCOPY ENDOSCOPY DEVICES 51
TABLE 21 MARKET SIZE FOR OF ARTHROSCOPY DEVICES, THROUGH 2018 ($
MILLIONS) 51
MAJOR PLAYERS IN ARTHROSCOPY MARKET 51
ENT ENDOSCOPY AND BRONCHOSCOPY 51
ENT ENDOSCOPY 51
NASAL SINOSCOPY 52
TRANSNASAL RESECTION OF BRAIN-BASED CANCERS 52
PEDICLED NASOSEPTAL FLAP PROTOCOL 53
THROAT ENDOSCOPY 54
Laryngoscopy 54
Bronchoscopy 55
Bronchoscope 55
Thoracoscopy 55
ENT AND BRONCHOSCOPY INSTRUMENT TYPE AND ACCESSORIES 56
MARKET SIZE FOR ENT AND BRONCHOSCOPY DEVICES 56
TABLE 22 MARKET SIZE FOR ENT AND BRONCHOSCOPY DEVICES, THROUGH 2018
($ MILLIONS) 56
MAJOR PLAYERS IN ENT AND BRONCHOSCOPY MARKET 57
GYNECOLOGY ENDOSCOPY 57
DIAGNOSTIC LAPAROSCOPY 57
TUBAL STERILIZATION 57
LYSIS OF ADHESION 58
TREATMENT OF ENDOMETRIOSIS 58
TREATMENT OF ECTOPIC PREGNANCY 58
OVARIAN CYSTECTOMY 58
HYSTERECTOMY 59
ONCOLOGIC PROCEDURES 59
GYNECOLOGY INSTRUMENT TYPE AND ACCESSORIES 59
MARKET SIZE FOR GYNECOLOGY DEVICES 60
TABLE 23 MARKET SIZE FOR GYNECOLOGY DEVICES, THROUGH 2018 ($ MILLIONS) 60
MAJOR PLAYERS IN GYNECOLOGY MARKET 60
NEUROLOGY ENDOSCOPY 60
HYDROCEPHALUS 61
COLLOID CYST REMOVAL 61
ARACHNOID CYST FENESTRATION 61
NEUROCYSTICERCOSIS 62
THORACIC AND LUMBAR DISC REMOVAL 62
Lumbar Disc 62
Thoracic Disc 63
Minimally Invasive Sympathotomy 63
Endoscopic Transthoracic Sympathotomy 64
Upper Limb Sympathetic-mediated Pain 64
ENDOSCOPE-ASSISTED SURGERIES 65
NEUROLOGY INSTRUMENT TYPE AND ACCESSORIES 65
MARKET SIZE FOR NEUROLOGY DEVICES 65
TABLE 24 MARKET SIZE FOR NEUROLOGY DEVICES, THROUGH 2018 ($ MILLIONS) 65
MAJOR PLAYERS IN THE NEUROLOGY MARKET 66
CHAPTER 5 GLOBAL ENDOSCOPY MARKET 68
SUMMARY 68
TABLE 25 TOTAL ENDOSCOPY MARKET, BY SEGMENT, THROUGH 2018 ($ MILLIONS) 68
INTRODUCTION 68
TABLE 26 GLOBAL DISTRIBUTION OF ENDOSCOPY REVENUE, 2011-2012 ($
MILLIONS) 69
INDIA 69
CHINA 69
JAPAN 70
OVERALL ENDOSCOPY MARKET 70
DRIVER OF ENDOSCOPY MARKET 71
RESISTORS TO ENDOSCOPY MARKET 71
MARKET SEGMENTS 72
ENDOSCOPES 72
Rigid Endoscopes 72
Flexible Endoscopes 72
ENDOSCOPIC ACCESSORIES 73
VISUALIZATION EQUIPMENT 73
ENDOSCOPY EQUIPMENT SERVICING 74
CHAPTER 6 ADVANCES IN ENDOSCOPE TECHNOLOGY 76
NARROW BAND IMAGING (NBI) 76
HIGH-DEFINITION IMAGING AND HD TV 76
THIRD EYE RETROSCOPE 76
DOUBLE-BALLOON ENDOSCOPY DEVICE 76
PILLCAM 77
PICTURE ARCHIVING AND COMMUNICATIONS SYSTEM (PACS) 77
NOTES 77
ROBOT-ASSISTED ENDOSCOPY 78
CHAPTER 7 ENDOSCOPY CLINICAL TRIALS WORLDWIDE 81
CLINICAL TRIALS 81
TABLE 27 ENDOSCOPY CLINICAL TRIALS WORLDWIDE 81
CHAPTER 8 MERGERS AND ACQUISITIONS 99
ACQUISITIONS 99
TABLE 28 ACQUISITIONS IN THE GLOBAL ENDOSCOPY DEVICE MARKET, 2007-2012
($ MILLIONS) 99
PARTNERSHIPS 102
TABLE 29 PARTNERSHIPS IN THE GLOBAL ENDOSCOPY DEVICE MARKET,
2007-2012 102
CHAPTER 9 COMPANY PROFILES OF MAJOR ENDOSCOPY MANUFACTURERS 107
BOSTON SCIENTIFIC CORPORATION 107
FINANCIAL PERFORMANCE 107
TABLE 30 BOSTON SCIENTIFIC REVENUE PERFORMANCE, THROUGH 2012 ($
MILLIONS) 107
KEY SEGMENTS AND PRODUCT PORTFOLIO 108
TABLE 31 BOSTON SCIENTIFIC PRODUCT PORTFOLIO 108
GROWTH STRATEGIES 109
SWOT ANALYSIS 109
TABLE 32 BOSTON SCIENTIFIC SWOT ANALYSIS 109
COVIDIEN 109
FINANCIAL PERFORMANCE 110
TABLE 33 COVIDIEN REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 110
KEY SEGMENTS AND PRODUCT PORTFOLIO 110
TABLE 34 COVIDIEN PRODUCT PORTFOLIO 110
GROWTH STRATEGIES 111
SWOT ANALYSIS 112
TABLE 35 COVIDIEN SWOT ANALYSIS 112
GIVEN IMAGING LTD. 112
FINANCIAL PERFORMANCE 113
TABLE 36 GIVEN IMAGING REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 113
GROWTH STRATEGIES 113
SWOT ANALYSIS 113
TABLE 37 GIVEN IMAGING SWOT ANALYSIS 113
JOHNSON and JOHNSON--ETHICON ENDO SURGERY (EES) 114
FINANCIAL PERFORMANCE 114
TABLE 38 ETHICON ENDO-SURGERY DEVICES REVENUE PERFORMANCE, THROUGH
2012 ($ MILLIONS) 114
KEY SEGMENTS AND PRODUCT PORTFOLIO 114
TABLE 39 ETHICON ENDO SURGERY PRODUCT PORTFOLIO 115
GROWTH STRATEGY 115
SWOT ANALYSIS 116
TABLE 40 ETHICON ENDO SURGERY SWOT ANALYSIS 116
KARL STORZ GMBH and CO. KG 116
FINANCIAL PERFORMANCE 117
TABLE 41 KARL STORZ REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 117
KEY SEGMENTS AND PRODUCT PORTFOLIO 117
TABLE 42 KARL STORZ PRODUCT PORTFOLIO 117
GROWTH STRATEGIES 118
SWOT ANALYSIS 118
TABLE 43 KARL STORZ SWOT ANALYSIS 118
OLYMPUS MEDICAL SYSTEMS 119
FINANCIAL PERFORMANCE 119
TABLE 44 OLYMPUS MEDICAL SYSTEMS REVENUE PERFORMANCE, THROUGH
20121 ($ MILLIONS) 119
KEY SEGMENTS AND PRODUCT PORTFOLIO 119
TABLE 45 OLYMPUS PRODUCT PORTFOLIO 120
GROWTH STRATEGIES 120
SWOT ANALYSIS 120
TABLE 46 OLYMPUS MEDICAL SYSTEMS SWOT ANALYSIS 120
SMITH and NEPHEW, INC. 121
FINANCIAL PERFORMANCE 121
TABLE 47 SMITH and NEPHEW REVENUE PERFORMANCE, THROUGH 2012 ($
MILLIONS) 121
KEY SEGMENTS AND PRODUCT PORTFOLIO 122
TABLE 48 SMITH and NEPHEW PRODUCT PORTFOLIO 122
GROWTH STRATEGIES 122
SWOT ANALYSIS 122
TABLE 49 SMITH and NEPHEW SWOT ANALYSIS 122
STRYKER 123
FINANCIAL PERFORMANCE 124
TABLE 50 STRYKER REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 124
KEY SEGMENTS AND PRODUCT PORTFOLIO 124
TABLE 51 STRYKER PRODUCT PORTFOLIO 124
GROWTH STRATEGIES 125
SWOT ANALYSIS 127
TABLE 52 STRYKER SWOT ANALYSIS 127
HLC093B - Endoscopy Devices: Applications and Global Markets
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com
LIST OF TABLES
TABLE HEADING PAGE NO.
SUMMARY TABLE TOTAL ENDOSCOPY MARKET, BY SEGMENT, THROUGH 2018 ($
MILLIONS) 7
TABLE 1 GLOBAL ENDOSCOPY REVENUES OF LEADING COMPANIES, THROUGH 2012
($ MILLIONS) 11
TABLE 2 LEADING PLAYERS IN VARIOUS ENDOSCOPY SEGMENTS 15
TABLE 3 KIDNEY DISEASES COMMONLY MANAGED BY ENDOSCOPY 22
TABLE 4 URETER DISEASES COMMONLY MANAGED BY ENDOSCOPY 22
TABLE 5 BLADDER DISEASES COMMONLY MANAGED BY ENDOSCOPY 23
TABLE 6 PROSTATE DISEASES COMMONLY MANAGED BY ENDOSCOPY 23
TABLE 7 URETHRA DISEASES COMMONLY MANAGED BY ENDOSCOPY 23
TABLE 8 MARKET SIZE FOR UROLOGICAL ENDOSCOPE DEVICES, THROUGH 2018 ($
MILLIONS) 25
TABLE 9 PENETRATION OF LAPAROSCOPY IN COMMON SURGICAL PROCEDURES IN
THE U.S., 2012 (NUMBER/%) 28
TABLE 10 COMMERCIALLY AVAILABLE MUCOSAL ABLATION THERAPY DEVICES 30
TABLE 11 MARKET SIZE FOR LAPAROSCOPY DEVICES, THROUGH 2018 ($ MILLIONS) 31
TABLE 12 KEY DEVICE TYPE FOR EMR PROCEDURE 35
TABLE 13 KEY DEVICE CATEGORIES FOR ENDOSCOPIC ULTRASOUND 36
TABLE 14 CLASSIFICATION OF STAINS USED IN CHROMOENDOSCOPY 39
TABLE 15 COMMERCIALLY AVAILABLE SPRAY CATHETERS 40
TABLE 16 MARKET SIZE FOR OF GI ENDOSCOPY DEVICES, THROUGH 2018 ($
MILLIONS) 41
TABLE 17 KNEE LIGAMENT DAMAGE AND SURGICAL REQUIREMENTS 44
TABLE 18 PROCEDURES ROUTINELY EMPLOYED IN ARTHROSCOPIC ROTATOR CUFF
SURGERY 46
TABLE 19 COMMON CONDITIONS REQUIRING ARTHROSCOPIC WRIST SURGERY 47
TABLE 20 SOME COMMON ELBOW DIAGNOSES REVEALED BY ARTHROSCOPIC
INVESTIGATION 49
TABLE 21 MARKET SIZE FOR OF ARTHROSCOPY DEVICES, THROUGH 2018 ($
MILLIONS) 51
TABLE 22 MARKET SIZE FOR ENT AND BRONCHOSCOPY DEVICES, THROUGH 2018 ($
MILLIONS) 56
TABLE 23 MARKET SIZE FOR GYNECOLOGY DEVICES, THROUGH 2018 ($ MILLIONS) 60
TABLE 24 MARKET SIZE FOR NEUROLOGY DEVICES, THROUGH 2018 ($ MILLIONS) 65
TABLE 25 TOTAL ENDOSCOPY MARKET, BY SEGMENT, THROUGH 2018 ($ MILLIONS) 68
TABLE 26 GLOBAL DISTRIBUTION OF ENDOSCOPY REVENUE, 2011-2012 ($ MILLIONS) 69
TABLE 27 ENDOSCOPY CLINICAL TRIALS WORLDWIDE 81
TABLE 28 ACQUISITIONS IN THE GLOBAL ENDOSCOPY DEVICE MARKET, 2007-2012
($ MILLIONS) 99
TABLE 29 PARTNERSHIPS IN THE GLOBAL ENDOSCOPY DEVICE MARKET, 2007-2012 102
TABLE 30 BOSTON SCIENTIFIC REVENUE PERFORMANCE, THROUGH 2012 ($
MILLIONS) 107
TABLE 31 BOSTON SCIENTIFIC PRODUCT PORTFOLIO 108
TABLE 32 BOSTON SCIENTIFIC SWOT ANALYSIS 109
TABLE 33 COVIDIEN REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 110
TABLE 34 COVIDIEN PRODUCT PORTFOLIO 110
TABLE 35 COVIDIEN SWOT ANALYSIS 112
TABLE 36 GIVEN IMAGING REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 113
TABLE 37 GIVEN IMAGING SWOT ANALYSIS 113
HLC093B - Endoscopy Devices: Applications and Global Markets
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com
TABLE HEADING PAGE NO.
TABLE 38 ETHICON ENDO-SURGERY DEVICES REVENUE PERFORMANCE, THROUGH
2012 ($ MILLIONS) 114
TABLE 39 ETHICON ENDO SURGERY PRODUCT PORTFOLIO 115
TABLE 40 ETHICON ENDO SURGERY SWOT ANALYSIS 116
TABLE 41 KARL STORZ REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 117
TABLE 42 KARL STORZ PRODUCT PORTFOLIO 117
TABLE 43 KARL STORZ SWOT ANALYSIS 118
TABLE 44 OLYMPUS MEDICAL SYSTEMS REVENUE PERFORMANCE, THROUGH 20121
($ MILLIONS) 119
TABLE 45 OLYMPUS PRODUCT PORTFOLIO 120
TABLE 46 OLYMPUS MEDICAL SYSTEMS SWOT ANALYSIS 120
TABLE 47 SMITH and NEPHEW REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 121
TABLE 48 SMITH and NEPHEW PRODUCT PORTFOLIO 122
TABLE 49 SMITH and NEPHEW SWOT ANALYSIS 122
TABLE 50 STRYKER REVENUE PERFORMANCE, THROUGH 2012 ($ MILLIONS) 124
TABLE 51 STRYKER PRODUCT PORTFOLIO 124
TABLE 52 STRYKER SWOT ANALYSIS 127
HLC093B - Endoscopy Devices: Applications and Global Markets
Copyright ©

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Emerging Trends in Neuromodulators (Technical Insights)

Emerging Trends in Neuromodulators (Technical Insights)

  • $ 6 500
  • Industry report
  • September 2014
  • by Frost & Sullivan

Exciting Technological and Business Vistas on the Horizon This research service showcases existing, emerging and cutting-edge Neuromodulation technologies. The report studies the role of Neuromodulation ...

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products...) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019

Regenerative Medicine Market (Bone and Joint) (By Technology - By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products...) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital ...

Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, Size, Share,

Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency, Light/Laser, Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, Size, Share,

  • $ 4 795
  • Industry report
  • July 2014
  • by Transparency Market Research

An ablation procedure is a minimally invasive process to remove unwanted tissue from the body by using various energy devices such as radiofrequency, microwave, ultrasound, electrical current, laser and ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.